Comparison between Flysbs Aviation IPO and GNH India Pharmaceuticals IPO.
Flysbs Aviation IPO is a SME Bookbuilding IPO proposed to list at NSE SME while GNH India Pharmaceuticals IPO is a SME Bookbuilding proposed to list at NSE SME.
| Flysbs Aviation IPO | GNH India Pharmaceuticals IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Vivro Financial Services Pvt.Ltd. | Gretex Corporate Services Ltd. |
| Registrar | MUFG Intime India Pvt.Ltd. | Purva Sharegistry (India) Pvt.Ltd. |
| Market Maker | Giriraj Stock Broking Pvt.Ltd. | Gretex Share Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL |
The total issue size of Flysbs Aviation IPO is up to ₹97.36 Cr whereas the issue size of the GNH India Pharmaceuticals IPO is up to ₹0.00 Cr. The final issue price of Flysbs Aviation IPO is ₹225.00 per share and of GNH India Pharmaceuticals IPO is .
| Flysbs Aviation IPO | GNH India Pharmaceuticals IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹210.00 per share | |
| Issue Price (Upper) | ₹225.00 per share | |
| Issue Price (Final) | ₹225.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 600 shares | |
| Fresh Issue Size | 43,27,200 shares | 37,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹97.36 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 43,27,200 shares | 0 shares |
| Issue Size Total (Amount) | up to ₹97.36 Cr | up to ₹0.00 Cr |
Flysbs Aviation IPO opens on Aug 01, 2025, while GNH India Pharmaceuticals IPO opens on . The closing date of Flysbs Aviation IPO and GNH India Pharmaceuticals IPO is Aug 05, 2025, and , respectively.
| Flysbs Aviation IPO | GNH India Pharmaceuticals IPO | |
|---|---|---|
| Anchor Bid Date | Jul 31, 2025 | |
| Issue Open | Aug 01, 2025 | |
| Issue Close | Aug 05, 2025 | |
| Basis Of Allotment (Tentative) | Aug 06, 2025 | |
| Initiation of Refunds (Tentative) | Aug 07, 2025 | |
| Credit of Share (Tentative) | Aug 07, 2025 | |
| Listing date (Tentative) | Aug 08, 2025 | |
| Anchor Lockin End date 1 | Sep 04, 2025 | |
| Anchor Lockin End date 2 | Nov 03, 2025 |
Flysbs Aviation IPO P/E ratio is 10.1, as compared to GNH India Pharmaceuticals IPO P/E ratio of .
| Flysbs Aviation IPO | GNH India Pharmaceuticals IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)Flysbs Aviation Ltd.'s revenue increased by 83% and profit after tax (PAT) rose by 153% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 44.08 | 100 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 32.47 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 10.1 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹389.33 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 32.25% | 22.99% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 41.80% | 21.49% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.14 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹22.28 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 32.25% | 16.81% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Flysbs Aviation IPO Retail Individual Investors (RII) are offered 15,15,600 shares while in GNH India Pharmaceuticals IPO retail investors are offered 15,15,600 shares. Qualified Institutional Buyers (QIB) are offered 8,65,800 shares in Flysbs Aviation IPO and in GNH India Pharmaceuticals IPO.
| Flysbs Aviation IPO | GNH India Pharmaceuticals IPO | |
|---|---|---|
| Anchor Investor Reservation | 12,96,000 shares | |
| Market Maker Reservation | 2,29,800 shares | |
| QIB | 8,65,800 shares | |
| NII | 6,49,800 shares | |
| RII | 15,15,600 shares | |
| Employee | 0 shares | |
| Others | ||
| Total | 43,27,200 shares |
Flysbs Aviation IPO subscribed 318.68x in total, whereas GNH India Pharmaceuticals IPO subscribed .
| Flysbs Aviation IPO | GNH India Pharmaceuticals IPO | |
|---|---|---|
| QIB (times) | 191.93x | |
| NII (times) | 563.64x | |
| Big NII (times) | 683.93x | |
| Small NII (times) | 323.07x | |
| RII (times) | 286.06x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 318.68x |
